SEC filing record
Primary Source · SEC.gov

Arches Medical Independents LLC

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2026-05-01Last filing 2026-05-01

Raised

$5M

Investors

37

Min Invest

$3,250

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Arches Medical Independents LLC is a Delaware limited liability company that filed a Form D with the SEC on May 1, 2026 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Arches Medical Independents LLC reported $5,398,585 sold from 37 investors of a $5,398,585 total offering as of the Form D filed May 1, 2026. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $3,250. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 44 Brattle Street, First Floor, Cambridge, MA 02138.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002052001
Entity NameArches Medical Independents LLC
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeLimited Liability Company
Jurisdiction of OrganizationDelaware
Issuer Address44 Brattle Street, First Floor, Cambridge, MA 02138
Phone(917) 287-3517
Industry / Fund TypeOther Health Care
Securities TypeEquity
First Sale DateMarch 9, 2026
Filing DateMay 1, 2026
Accession Number0002052001-26-000002
Total Offering Amount$5,398,585
Total Amount Sold$5,398,585
Amount Remaining$0
Amount Sold NoteCombined figure across related vehicles: Two transactions took place: (i) common units were issued in exchange offer; no capital was raised and (ii) capital was raised in a sale of preferred units. This item includes value of common units as well as proceeds from sale of preferred units.
Total Investors37
Non-Accredited InvestorsNone
Minimum Investment$3,250
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeDecline to Disclose
State (Issuer Address)MA
Amendment Count2 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

2

latest May 1, 2026

Critical / warning

0 / 0

0 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

2

lapsed, closed

Latest event New filer · May 1, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 2 filing events with values and deltas, latest 2026-05-01, and alerts on the next one
  • 2 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

J. Christian Kryder

Executive Officer, Director, Promoter · Cambridge, MA

David Christian Gellis

Executive Officer · Cambridge, MA

Todd Christian Stockard

Executive Officer, Director · Cambridge, MA

Manoj Christian Mathew

Executive Officer · Cambridge, MA

Carlos Christian Rivera

Executive Officer, Director · Cambridge, MA

Questions About Arches Medical Independents LLC

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Arches Medical Independents LLC?

Arches Medical Independents LLC is a Delaware limited liability company that filed a Form D with the SEC on May 1, 2026 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.

Is Arches Medical Independents LLC legit?

AltStreet does not rate legitimacy; it reports the public record. Arches Medical Independents LLC filed a Form D with the SEC on May 1, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $5,398,585 sold to 37 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Arches Medical Independents LLC registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Arches Medical Independents LLC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Arches Medical Independents LLC raised?

Arches Medical Independents LLC reported $5,398,585 sold from 37 investors of a $5,398,585 total offering as of the Form D filed May 1, 2026. The filing states that the figure is combined across related vehicles, so it is not this entity's figure alone.

Who can invest in Arches Medical Independents LLC?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $3,250.

What is the minimum investment in Arches Medical Independents LLC?

The Form D lists $3,250 as the minimum investment accepted from any outside investor as of May 1, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Arches Medical Independents LLC and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Arches Medical Independents LLC?

The Form D lists 5 related persons: J. Christian Kryder, executive officer, director, promoter; David Christian Gellis, executive officer; Todd Christian Stockard, executive officer, director; Manoj Christian Mathew, executive officer; Carlos Christian Rivera, executive officer, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Arches Medical Independents LLC located?

The issuer's address on its SEC filings is 44 Brattle Street, First Floor, Cambridge, MA 02138. Its phone number of record is 917-287-3517. It is organized under the laws of Delaware.

How long is the Arches Medical Independents LLC offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is Arches Medical Independents LLC's revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.